NCT03139422

Treatment of Copper Intra Uterine Device Associated Heavy Menstrual Blood Loss

Tranexamic Acid Versus Calcium Dobesilate for the Treatment of Copper Intra Uterine Contraceptive Device Associated Heavy Menstrual Blood Loss : A Randomized , Open-labelled , Clinical Trial.

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 140 (estimated)
• Sponsor: Assiut University · Academic / Other
• Sex: Female
• Age: 20 Years – 40 Years
• Healthy volunteers: Not accepted

Summary

Intrauterine contraceptive device is the most commonly reversible method used among women of reproductive age worldwide. Almost one in five married contraceptive users is currently using Intrauterine contraceptive device. The Egyptian demographic and health survey results indicate that 30% of currently married women interviewed in the Egyptian demographic and health survey were using Intrauterine contraceptive device. Main reasons for discontinuation of Intrauterine contraceptive device as cited by women were excessive bleeding per vagina 39.68%, abdominal pain 38.62%, low backache35.97%.

Conditions

• Menorrhagia

Interventions

Type	Name	Description
DRUG	Tranexamic Acid 500 MG	oral tablets
DRUG	Calcium Dobesilate	oral tablets

Timeline

• Start date: 2017-07-01
• Primary completion: 2018-10-01
• Completion: 2018-12-01
• First posted: 2017-05-04
• Last updated: 2018-06-27

Locations

1 site across 1 country: Egypt